Acadia Healthcare's (ACHC) stock plummeted by a staggering 22.39% in pre-market trading on Friday, following the release of disappointing fourth-quarter 2024 financial results and a lacklustre full-year 2025 guidance.
The leading provider of behavioral healthcare services reported revenue of $774.2 million for the fourth quarter, missing the consensus estimate of $779 million. Additionally, the company's adjusted EBITDA of $153.1 million fell short of the expected $171.4 million, despite posting a net income of $33.5 million for the quarter.
Looking ahead, Acadia's full-year 2025 guidance further dampened investor sentiment. The company forecasted revenue in the range of $3.3 billion to $3.4 billion and adjusted EBITDA between $675 million and $725 million, both falling below analysts' expectations. Acadia also anticipated capital expenditures ranging from $525 million to $575 million as it continues to invest in expanding its psychiatric bed capacity to meet the growing demand for mental health services.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。